Frequently Asked Questions

Our FAQ page offers essential details about Chirayu Super Speciality Hospital's services, treatments, and appointment booking. Find answers to common questions about our specialized medical care, diagnostic tests, and treatment options. This resource ensures a smooth, informed experience when accessing our comprehensive healthcare services.

1. What types of myomectomy are available?

Types include abdominal, laparoscopic, robotic-assisted, and hysteroscopic myomectomy, depending on the fibroid’s location and size.

2. Free Dialysis Hospital

Free dialysis refers to the provision of dialysis treatments at no cost to the patient. It includes all necessary procedures and care associated with the dialysis process.

Eligibility criteria may include financial need, lack of insurance, or specific medical conditions. Please contact our patient services for detailed eligibility requirements.

For more information, please visit our website, call our helpline, or visit our patient services department at Chirayu Super Speciality Hospital. Our team is ready to assist you with any questions or concerns.

Our program combines advanced technology with compassionate care, ensuring high-quality treatment without financial burden. Our dedicated team of specialists is committed to your well-being.

We maintain strict protocols and use state-of-the-art equipment. Our experienced nephrologists and trained staff provide personalized care to each patient, ensuring the highest standards of treatment.

3. ANTI DS DNA

The Anti-dsDNA Antibody Test detects antibodies against double-stranded DNA, which are commonly associated with autoimmune diseases like Systemic Lupus Erythematosus (SLE).

This test is used to diagnose SLE, monitor disease activity, assess treatment response, and differentiate between autoimmune diseases.

No special preparation is needed. You can eat and drink normally. Inform your healthcare provider about any medications or health conditions.

Results are typically available within 1 to 2 days after the test.

A positive result suggests the presence of antibodies associated with autoimmune activity, particularly in Systemic Lupus Erythematosus (SLE). Further evaluation is often required to confirm the diagnosis and assess disease activity.